Richard Gilbert, Author at Diabetes Care Community

Richard Gilbert

Richard Gilbert is Professor of Medicine at the University of Toronto, Canada Research Chair in Diabetes Complications and Head of the Division of Endocrinology at St. Michael’s Hospital in Toronto. His major interests are in the treatment and prevention of diabetic complications with an emphasis on diabetic kidney disease. Professor Gilbert has published over 230 peer-reviewed manuscripts, has numerous patents on novel treatments for diabetic nephropathy and co-founded Fibrotech, a biotechnology company that has brought anti-fibrotic therapies from the bench to early phase human trials. He is currently a member of the editorial board of Diabetes. Current research projects relate to the use of new therapies for the prevention and treatment of chronic kidney disease and associated heart failure. In addition to his bench research, Dr. Gilbert is actively involved in teaching and knowledge translation. He currently heads Guidelines Committees for the management of hypertension in diabetes.

Stem cell treatment for diabetic kidney disease: the future is now

Richard Gilbert September 11, 2016 Management, Managing complications

The kidney plays a vital role in removing toxins from the body, while ensuring that the needed elements are retained. For reasons that are not certain, high blood glucose levels cause a build-up of scar tissue in the kidney that prevents it from being able to filter blood in the way that it normally does.